More than ever, clinicians need regularly updated reviews given the continuously increasing
amount of new information regarding innovative cervical cancer prevention methods. A …

Cervical cancer is the second most common cancer in women worldwide, and knowledge
regarding its cause and pathogenesis is expanding rapidly. Persistent infection with one of …

Background The quadrivalent human papillomavirus (HPV) vaccine was shown to prevent
infections and lesions related to HPV6, 11, 16, and 18 in a randomised, placebo-controlled …

Cervical cancer is caused by human papillomavirus infection. Most human papillomavirus
infection is harmless and clears spontaneously but persistent infection with high-risk human …

Background HPV testing is replacing cytology for cervical cancer screening because of
greater sensitivity and superior reassurance following negative tests for the dozen HPV …

Background. Baseline information on human papillomavirus (HPV) prevalence and type
distribution is highly desirable to evaluate the impact of prophylactic HPV vaccines in the …

Context Human papillomavirus (HPV) infection is the principal cause of a distinct form of
oropharyngeal squamous cell carcinoma that is increasing in incidence among men in the …

Human papillomaviruses (HPVs) cause cancer at multiple anatomic sites in men and
women, including cervical, oropharyngeal, anal, vulvar and vaginal cancers in women and …

Human papilloma viruses (HPV) are a small group of non‑enveloped viruses belonging to
the Papillomaviridae family with strong similarities to polyoma viruses. The viral particles …

Worldwide human papillomavirus (HPV) prevalence in women with normal cytology at any
given point in time is approximately 10% indicating that HPV is one of the most common …